Advertisement

Insulin Resistance and Type 2 Diabetes as Microdomain Disease: Implication of Ganglioside GM3

  • Jin-ichi Inokuchi
  • Kazuya Kabayama

Abstract

Caveolae are a subset of membrane microdomains (lipid raft) particularly abundant in adipocytes. Critical dependence of the insulin metabolic signal transduction on caveolae/microdomains in adipocytes has been demonstrated. These microdomains can be biochemically isolated with their detergent insolubility and were designated as detergent resistant microdomains (DRM). Gangliosides are known as structurally and functionally important components in microdomains. We demonstrated that increased GM3 expression was accompanied in the state of insulin resistance in mouse 3T3-L1 adipocytes induced by TNFα and in the adipose tissues of obese/diabetic rodent models such as Zucker fa/fa rats and ob/ob mice (Tagami et al. 2002). We examined the effect of TNFα on the composition and function of DRM in adipocytes and demonstrated that increased GM3 levels result in the elimination of insulin receptor (IR) from the DRM while caveolin and flotillin remain in the DRM, leading to the inhibition of insulin’s metabolic signaling (Kabayama et al. 2005). These findings are further supported by the report that mice lacking GM3 synthase exhibit enhanced insulin signaling (Yamashita et al. 2003). Thus, we present a new pathological feature of insulin resistance in adipocytes induced by TNFα.

Keywords

Insulin Resistance Insulin Receptor Ultracentrifuge Tube Detergent Insolubility Assay Fluorescence Microscope 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Guo D, Donner DB (1996) Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 271:615–618PubMedCrossRefGoogle Scholar
  2. Inokuchi J, Kabayama K (2007) Receptor modifications in glycobiology. In: Kamerling JP (ed) Comprehensive glycoscience, 3:733–744, Elsevier, AmsterdamGoogle Scholar
  3. Kabayama K, Sato T, Kitamura F, Uemura S, Kang BW, Igarashi Y, Inokuchi J (2005) TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology 15:21–29PubMedCrossRefGoogle Scholar
  4. Kabayama K, Sato T, Saito K, Loberto N, Prinetti A, Sonnino S, Kinjo M, Igarashi Y, Inokuchi J (2007) Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci USA 104:13678–13683PubMedCrossRefGoogle Scholar
  5. Tagami S, Inokuchi J, Kabayama K, Yoshimura H, Kitamura F, Uemura S, Ogawa C, Ishii A, Saito M, Ohtsuka Y, Sakaue S, Igarashi Y (2002) Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem 277:3085–3092PubMedCrossRefGoogle Scholar
  6. Yamashita T, Hashiramoto A, Haluzik M, Mizukami H, Beck S, Norton A, Kono M, Tsuji S, Daniotti JL, Werth N, Sandhoff R, Sandhoff K, Proia RL (2003) Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA 100:3445–3449PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Jin-ichi Inokuchi
    • 1
  • Kazuya Kabayama
    • 1
  1. 1.Division of Glycopathology and CREST, Japan Science and Technology Agency, Institute of Molecular Biomembranes and GlycobiologyTohoku Pharmaceutical UniversitySendaiJapan

Personalised recommendations